DOI:
10.1055/s-00000007
Aktuelle Urologie
LinksClose Window
References
Abrams P, Cardozo L, Chapple C. et al.
Comparison of the efficacy, safety, and tolerability of propiverine and oxybutynin for the treatment of overactive bladder syndrome.
Int J Urol 2006;
13: 692-698
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.